Biovail Abandons Wellbutrin Litigation
On Monday, Biovail revealed that it had reached an agreement with Anchen Pharmaceuticals LLP, Impax Laboratories Inc., Watson Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. in its long-standing battle over Wellbutrin XL.
Biovail had begun legal proceedings against the companies in 2005 after they filed abbreviated new drug applications...
Already a subscriber? Click here to login